146 related articles for article (PubMed ID: 12214070)
61. Localization of CHMP2B-immunoreactivity in the brainstem of Lewy body disease.
Kurashige T; Takahashi T; Yamazaki Y; Hiji M; Izumi Y; Yamawaki T; Matsumoto M
Neuropathology; 2013 Jun; 33(3):237-45. PubMed ID: 22989140
[TBL] [Abstract][Full Text] [Related]
62. Enteric GFAP expression and phosphorylation in Parkinson's disease.
Clairembault T; Kamphuis W; Leclair-Visonneau L; Rolli-Derkinderen M; Coron E; Neunlist M; Hol EM; Derkinderen P
J Neurochem; 2014 Sep; 130(6):805-15. PubMed ID: 24749759
[TBL] [Abstract][Full Text] [Related]
63. The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease.
Jellinger K
J Neurol Neurosurg Psychiatry; 1988 Apr; 51(4):540-3. PubMed ID: 3379428
[TBL] [Abstract][Full Text] [Related]
64. Severity of gliosis in Pick's disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders.
Schofield E; Kersaitis C; Shepherd CE; Kril JJ; Halliday GM
Brain; 2003 Apr; 126(Pt 4):827-40. PubMed ID: 12615642
[TBL] [Abstract][Full Text] [Related]
65. Mechanisms of neuronal death in Alzheimer's disease.
Cotman CW; Su JH
Brain Pathol; 1996 Oct; 6(4):493-506. PubMed ID: 8944319
[TBL] [Abstract][Full Text] [Related]
66. LRRK2 p.Ile1371Val Mutation in a Case with Neuropathologically Confirmed Multi-System Atrophy.
Lee K; Nguyen KD; Sun C; Liu M; Zafar F; Saetern J; Flierl A; Tetrud JW; Langston JW; Dickson D; Schüle B
J Parkinsons Dis; 2018; 8(1):93-100. PubMed ID: 29480226
[TBL] [Abstract][Full Text] [Related]
67. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease.
Ishizawa K; Ksiezak-Reding H; Davies P; Delacourte A; Tiseo P; Yen SH; Dickson DW
Acta Neuropathol; 2000 Sep; 100(3):235-44. PubMed ID: 10965792
[TBL] [Abstract][Full Text] [Related]
68. FBXO7 immunoreactivity in α-synuclein-containing inclusions in Parkinson disease and multiple system atrophy.
Zhao T; Severijnen LA; van der Weiden M; Zheng PP; Oostra BA; Hukema RK; Willemsen R; Kros JM; Bonifati V
J Neuropathol Exp Neurol; 2013 Jun; 72(6):482-8. PubMed ID: 23656991
[TBL] [Abstract][Full Text] [Related]
69. Frequent globular neuronal cytoplasmic inclusions in the medial temporal region as a possible characteristic feature in multiple system atrophy with dementia.
Homma T; Mochizuki Y; Komori T; Isozaki E
Neuropathology; 2016 Oct; 36(5):421-431. PubMed ID: 26970514
[TBL] [Abstract][Full Text] [Related]
70. Caspase-cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in Alzheimer's disease and Down's syndrome brain.
Su JH; Kesslak JP; Head E; Cotman CW
Acta Neuropathol; 2002 Jul; 104(1):1-6. PubMed ID: 12070657
[TBL] [Abstract][Full Text] [Related]
71. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
Chalmers KA; Love S
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
[TBL] [Abstract][Full Text] [Related]
72. [The application of Gallyas-Braak stainings in pathologic diagnosis of neurodegenerative diseases].
Wang L; Zhu M; Li X; Gui Q
Zhonghua Nei Ke Za Zhi; 2002 Feb; 41(2):120-3. PubMed ID: 11940310
[TBL] [Abstract][Full Text] [Related]
73. Evidence of early involvement of apoptosis inducing factor-induced neuronal death in Alzheimer brain.
Lee JH; Cheon YH; Woo RS; Song DY; Moon C; Baik TK
Anat Cell Biol; 2012 Mar; 45(1):26-37. PubMed ID: 22536549
[TBL] [Abstract][Full Text] [Related]
74. Mechanisms of cell death in Alzheimer's disease.
Bancher C; Lassmann H; Breitschopf H; Jellinger KA
J Neural Transm Suppl; 1997; 50():141-52. PubMed ID: 9120414
[TBL] [Abstract][Full Text] [Related]
75. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies.
Ferrer I; Hernández I; Boada M; Llorente A; Rey MJ; Cardozo A; Ezquerra M; Puig B
Acta Neuropathol; 2003 Nov; 106(5):419-35. PubMed ID: 12955398
[TBL] [Abstract][Full Text] [Related]
76. Brain Accumulation of Amyloid-beta in Non-Alzheimer Neurodegeneration.
Primavera J; Lu BX; Riskind PJ; Iulian M; De La Monte SM
J Alzheimers Dis; 1999 Oct; 1(3):183-193. PubMed ID: 12214003
[TBL] [Abstract][Full Text] [Related]
77. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Bukhatwa S; Zeng BY; Rose S; Jenner P
Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003
[TBL] [Abstract][Full Text] [Related]
78. Tau pathology in aged cynomolgus monkeys is progressive supranuclear palsy/corticobasal degeneration- but not Alzheimer disease-like -Ultrastructural mapping of tau by EDX.
Uchihara T; Endo K; Kondo H; Okabayashi S; Shimozawa N; Yasutomi Y; Adachi E; Kimura N
Acta Neuropathol Commun; 2016 Nov; 4(1):118. PubMed ID: 27842611
[TBL] [Abstract][Full Text] [Related]
79. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
Orimo S
Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
[TBL] [Abstract][Full Text] [Related]
80. Disease-specific selective vulnerability and neuroimmune pathways in dementia revealed by single cell genomics.
Rexach JE; Cheng Y; Chen L; Polioudakis D; Lin LC; Mitri V; Elkins A; Yin A; Calini D; Kawaguchi R; Ou J; Huang J; Williams C; Robinson J; Gaus SE; Spina S; Lee EB; Grinberg LT; Vinters H; Trojanowski JQ; Seeley WW; Malhotra D; Geschwind DH
bioRxiv; 2023 Sep; ():. PubMed ID: 37808727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
